nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—PRPF4—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.386	CbGdCrCtD
Sunitinib—PRPF4—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.332	CbGdCrCtD
Sunitinib—CSNK1A1—respiratory system—chronic obstructive pulmonary disease	0.00107	0.00357	CbGeAlD
Sunitinib—STK39—trachea—chronic obstructive pulmonary disease	0.00107	0.00355	CbGeAlD
Sunitinib—CLK1—respiratory system—chronic obstructive pulmonary disease	0.00107	0.00355	CbGeAlD
Sunitinib—TNK1—bronchus—chronic obstructive pulmonary disease	0.00106	0.00353	CbGeAlD
Sunitinib—ROCK1—connective tissue—chronic obstructive pulmonary disease	0.00106	0.00352	CbGeAlD
Sunitinib—CSNK2A1—trachea—chronic obstructive pulmonary disease	0.00105	0.0035	CbGeAlD
Sunitinib—MAP4K1—bronchus—chronic obstructive pulmonary disease	0.00105	0.0035	CbGeAlD
Sunitinib—STK17A—lung—chronic obstructive pulmonary disease	0.00105	0.00349	CbGeAlD
Sunitinib—CAMK2G—respiratory system—chronic obstructive pulmonary disease	0.00105	0.00348	CbGeAlD
Sunitinib—MYLK—trachea—chronic obstructive pulmonary disease	0.00104	0.00346	CbGeAlD
Sunitinib—LRRK2—respiratory system—chronic obstructive pulmonary disease	0.00104	0.00345	CbGeAlD
Sunitinib—CDK14—lung—chronic obstructive pulmonary disease	0.00103	0.00344	CbGeAlD
Sunitinib—DAPK3—bronchus—chronic obstructive pulmonary disease	0.00103	0.00343	CbGeAlD
Sunitinib—CLK2—bronchus—chronic obstructive pulmonary disease	0.00102	0.0034	CbGeAlD
Sunitinib—PRKAA1—respiratory system—chronic obstructive pulmonary disease	0.00102	0.0034	CbGeAlD
Sunitinib—LATS2—lung—chronic obstructive pulmonary disease	0.00102	0.00339	CbGeAlD
Sunitinib—PAK3—lung—chronic obstructive pulmonary disease	0.00102	0.00339	CbGeAlD
Sunitinib—CDK16—lung—chronic obstructive pulmonary disease	0.00102	0.00339	CbGeAlD
Sunitinib—PTK2B—respiratory system—chronic obstructive pulmonary disease	0.00101	0.00336	CbGeAlD
Sunitinib—DAPK3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00101	0.00336	CbGeAlD
Sunitinib—FLT4—respiratory system—chronic obstructive pulmonary disease	0.00101	0.00335	CbGeAlD
Sunitinib—RPS6KA5—lung—chronic obstructive pulmonary disease	0.001	0.00334	CbGeAlD
Sunitinib—STK33—lung—chronic obstructive pulmonary disease	0.001	0.00334	CbGeAlD
Sunitinib—STK3—bronchus—chronic obstructive pulmonary disease	0.001	0.00334	CbGeAlD
Sunitinib—STK24—trachea—chronic obstructive pulmonary disease	0.000996	0.00331	CbGeAlD
Sunitinib—CSNK1E—respiratory system—chronic obstructive pulmonary disease	0.000993	0.00331	CbGeAlD
Sunitinib—MAP4K4—connective tissue—chronic obstructive pulmonary disease	0.00099	0.0033	CbGeAlD
Sunitinib—DAPK2—trachea—chronic obstructive pulmonary disease	0.000985	0.00328	CbGeAlD
Sunitinib—FLT3—connective tissue—chronic obstructive pulmonary disease	0.000976	0.00325	CbGeAlD
Sunitinib—ROCK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000968	0.00322	CbGeAlD
Sunitinib—CLK4—lung—chronic obstructive pulmonary disease	0.000967	0.00322	CbGeAlD
Sunitinib—RPS6KA3—connective tissue—chronic obstructive pulmonary disease	0.000963	0.0032	CbGeAlD
Sunitinib—MAP2K2—respiratory system—chronic obstructive pulmonary disease	0.000956	0.00318	CbGeAlD
Sunitinib—MAP2K1—connective tissue—chronic obstructive pulmonary disease	0.000956	0.00318	CbGeAlD
Sunitinib—ITK—lung—chronic obstructive pulmonary disease	0.000955	0.00318	CbGeAlD
Sunitinib—TNK1—trachea—chronic obstructive pulmonary disease	0.000954	0.00317	CbGeAlD
Sunitinib—CLK1—connective tissue—chronic obstructive pulmonary disease	0.000938	0.00312	CbGeAlD
Sunitinib—DAPK1—lung—chronic obstructive pulmonary disease	0.000934	0.00311	CbGeAlD
Sunitinib—TBK1—respiratory system—chronic obstructive pulmonary disease	0.00093	0.00309	CbGeAlD
Sunitinib—MAP4K4—bronchus—chronic obstructive pulmonary disease	0.000926	0.00308	CbGeAlD
Sunitinib—TYK2—respiratory system—chronic obstructive pulmonary disease	0.000924	0.00307	CbGeAlD
Sunitinib—BMP2K—connective tissue—chronic obstructive pulmonary disease	0.00092	0.00306	CbGeAlD
Sunitinib—CLK2—trachea—chronic obstructive pulmonary disease	0.000917	0.00305	CbGeAlD
Sunitinib—MAP3K12—bronchus—chronic obstructive pulmonary disease	0.000912	0.00304	CbGeAlD
Sunitinib—MAP4K4—smooth muscle tissue—chronic obstructive pulmonary disease	0.000906	0.00301	CbGeAlD
Sunitinib—STK11—lung—chronic obstructive pulmonary disease	0.000904	0.00301	CbGeAlD
Sunitinib—BRD4—lung—chronic obstructive pulmonary disease	0.000904	0.00301	CbGeAlD
Sunitinib—RPS6KA3—bronchus—chronic obstructive pulmonary disease	0.0009	0.003	CbGeAlD
Sunitinib—PRKAA1—connective tissue—chronic obstructive pulmonary disease	0.000899	0.00299	CbGeAlD
Sunitinib—RPS6KA1—lung—chronic obstructive pulmonary disease	0.000895	0.00298	CbGeAlD
Sunitinib—RIOK1—lung—chronic obstructive pulmonary disease	0.000895	0.00298	CbGeAlD
Sunitinib—RPS6KB1—respiratory system—chronic obstructive pulmonary disease	0.000894	0.00298	CbGeAlD
Sunitinib—FGR—respiratory system—chronic obstructive pulmonary disease	0.000889	0.00296	CbGeAlD
Sunitinib—PTK2B—connective tissue—chronic obstructive pulmonary disease	0.000889	0.00296	CbGeAlD
Sunitinib—AXL—respiratory system—chronic obstructive pulmonary disease	0.000885	0.00295	CbGeAlD
Sunitinib—CSNK1A1—bronchus—chronic obstructive pulmonary disease	0.000882	0.00294	CbGeAlD
Sunitinib—TNIK—lung—chronic obstructive pulmonary disease	0.000878	0.00292	CbGeAlD
Sunitinib—MARK2—lung—chronic obstructive pulmonary disease	0.000878	0.00292	CbGeAlD
Sunitinib—CLK1—bronchus—chronic obstructive pulmonary disease	0.000877	0.00292	CbGeAlD
Sunitinib—MAP2K1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000875	0.00291	CbGeAlD
Sunitinib—SGK3—lung—chronic obstructive pulmonary disease	0.000869	0.00289	CbGeAlD
Sunitinib—CSNK1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000863	0.00287	CbGeAlD
Sunitinib—ICK—lung—chronic obstructive pulmonary disease	0.000862	0.00287	CbGeAlD
Sunitinib—BMP2K—bronchus—chronic obstructive pulmonary disease	0.00086	0.00286	CbGeAlD
Sunitinib—TLK2—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.000846	0.123	CbGdCrCtD
Sunitinib—FGFR2—respiratory system—chronic obstructive pulmonary disease	0.000845	0.00281	CbGeAlD
Sunitinib—JAK2—respiratory system—chronic obstructive pulmonary disease	0.00084	0.0028	CbGeAlD
Sunitinib—MAP3K2—connective tissue—chronic obstructive pulmonary disease	0.000836	0.00278	CbGeAlD
Sunitinib—CHEK2—lung—chronic obstructive pulmonary disease	0.000832	0.00277	CbGeAlD
Sunitinib—NUAK1—lung—chronic obstructive pulmonary disease	0.000832	0.00277	CbGeAlD
Sunitinib—MAP4K4—trachea—chronic obstructive pulmonary disease	0.000831	0.00277	CbGeAlD
Sunitinib—FYN—respiratory system—chronic obstructive pulmonary disease	0.000829	0.00276	CbGeAlD
Sunitinib—INSR—lung—chronic obstructive pulmonary disease	0.000825	0.00275	CbGeAlD
Sunitinib—OXSR1—lung—chronic obstructive pulmonary disease	0.000825	0.00275	CbGeAlD
Sunitinib—SNRK—lung—chronic obstructive pulmonary disease	0.000825	0.00275	CbGeAlD
Sunitinib—NUAK2—trachea—chronic obstructive pulmonary disease	0.000825	0.00275	CbGeAlD
Sunitinib—CSNK1E—bronchus—chronic obstructive pulmonary disease	0.000818	0.00272	CbGeAlD
Sunitinib—FGFR1—bronchus—chronic obstructive pulmonary disease	0.000818	0.00272	CbGeAlD
Sunitinib—PTK2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000813	0.00271	CbGeAlD
Sunitinib—TYK2—connective tissue—chronic obstructive pulmonary disease	0.000813	0.00271	CbGeAlD
Sunitinib—STK38—lung—chronic obstructive pulmonary disease	0.000812	0.0027	CbGeAlD
Sunitinib—RPS6KA2—lung—chronic obstructive pulmonary disease	0.000812	0.0027	CbGeAlD
Sunitinib—RPS6KA3—trachea—chronic obstructive pulmonary disease	0.000808	0.00269	CbGeAlD
Sunitinib—IRAK4—bronchus—chronic obstructive pulmonary disease	0.000805	0.00268	CbGeAlD
Sunitinib—CSNK1G2—lung—chronic obstructive pulmonary disease	0.0008	0.00266	CbGeAlD
Sunitinib—PKN1—lung—chronic obstructive pulmonary disease	0.0008	0.00266	CbGeAlD
Sunitinib—CSNK1A1—trachea—chronic obstructive pulmonary disease	0.000792	0.00264	CbGeAlD
Sunitinib—PRPF4—lung—chronic obstructive pulmonary disease	0.000788	0.00262	CbGeAlD
Sunitinib—RPS6KB1—connective tissue—chronic obstructive pulmonary disease	0.000787	0.00262	CbGeAlD
Sunitinib—CLK1—trachea—chronic obstructive pulmonary disease	0.000787	0.00262	CbGeAlD
Sunitinib—MAP2K2—bronchus—chronic obstructive pulmonary disease	0.000787	0.00262	CbGeAlD
Sunitinib—ULK3—bronchus—chronic obstructive pulmonary disease	0.000787	0.00262	CbGeAlD
Sunitinib—FLT1—respiratory system—chronic obstructive pulmonary disease	0.000783	0.00261	CbGeAlD
Sunitinib—RET—connective tissue—chronic obstructive pulmonary disease	0.000783	0.0026	CbGeAlD
Sunitinib—AXL—connective tissue—chronic obstructive pulmonary disease	0.000779	0.00259	CbGeAlD
Sunitinib—PRPF4B—lung—chronic obstructive pulmonary disease	0.000777	0.00259	CbGeAlD
Sunitinib—MAP3K7—bronchus—chronic obstructive pulmonary disease	0.000774	0.00258	CbGeAlD
Sunitinib—MAP2K2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00077	0.00256	CbGeAlD
Sunitinib—STK39—lung—chronic obstructive pulmonary disease	0.000766	0.00255	CbGeAlD
Sunitinib—TBK1—bronchus—chronic obstructive pulmonary disease	0.000765	0.00255	CbGeAlD
Sunitinib—TYK2—bronchus—chronic obstructive pulmonary disease	0.00076	0.00253	CbGeAlD
Sunitinib—MAP3K7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000757	0.00252	CbGeAlD
Sunitinib—CSNK2A1—lung—chronic obstructive pulmonary disease	0.000756	0.00252	CbGeAlD
Sunitinib—PRKAA1—trachea—chronic obstructive pulmonary disease	0.000755	0.00251	CbGeAlD
Sunitinib—IRAK1—bronchus—chronic obstructive pulmonary disease	0.00075	0.0025	CbGeAlD
Sunitinib—YES1—respiratory system—chronic obstructive pulmonary disease	0.000748	0.00249	CbGeAlD
Sunitinib—MYLK—lung—chronic obstructive pulmonary disease	0.000746	0.00248	CbGeAlD
Sunitinib—TYK2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000744	0.00248	CbGeAlD
Sunitinib—FGFR2—connective tissue—chronic obstructive pulmonary disease	0.000744	0.00247	CbGeAlD
Sunitinib—STK10—respiratory system—chronic obstructive pulmonary disease	0.000741	0.00247	CbGeAlD
Sunitinib—JAK2—connective tissue—chronic obstructive pulmonary disease	0.00074	0.00246	CbGeAlD
Sunitinib—TAOK3—respiratory system—chronic obstructive pulmonary disease	0.000738	0.00246	CbGeAlD
Sunitinib—PLK4—lung—chronic obstructive pulmonary disease	0.000737	0.00245	CbGeAlD
Sunitinib—RPS6KB1—bronchus—chronic obstructive pulmonary disease	0.000736	0.00245	CbGeAlD
Sunitinib—CSNK1E—trachea—chronic obstructive pulmonary disease	0.000734	0.00244	CbGeAlD
Sunitinib—IRAK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000734	0.00244	CbGeAlD
Sunitinib—PDGFRA—respiratory system—chronic obstructive pulmonary disease	0.000734	0.00244	CbGeAlD
Sunitinib—STK4—lung—chronic obstructive pulmonary disease	0.000733	0.00244	CbGeAlD
Sunitinib—FYN—connective tissue—chronic obstructive pulmonary disease	0.000729	0.00243	CbGeAlD
Sunitinib—IRAK4—trachea—chronic obstructive pulmonary disease	0.000723	0.00241	CbGeAlD
Sunitinib—RPS6KB1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00072	0.0024	CbGeAlD
Sunitinib—PHKG2—lung—chronic obstructive pulmonary disease	0.00072	0.0024	CbGeAlD
Sunitinib—STK24—lung—chronic obstructive pulmonary disease	0.000715	0.00238	CbGeAlD
Sunitinib—AXL—smooth muscle tissue—chronic obstructive pulmonary disease	0.000713	0.00237	CbGeAlD
Sunitinib—DAPK2—lung—chronic obstructive pulmonary disease	0.000707	0.00235	CbGeAlD
Sunitinib—ULK3—trachea—chronic obstructive pulmonary disease	0.000707	0.00235	CbGeAlD
Sunitinib—SLK—bronchus—chronic obstructive pulmonary disease	0.000701	0.00233	CbGeAlD
Sunitinib—STK16—lung—chronic obstructive pulmonary disease	0.000696	0.00232	CbGeAlD
Sunitinib—MAP3K7—trachea—chronic obstructive pulmonary disease	0.000695	0.00231	CbGeAlD
Sunitinib—HIPK2—lung—chronic obstructive pulmonary disease	0.000692	0.0023	CbGeAlD
Sunitinib—HIPK3—lung—chronic obstructive pulmonary disease	0.000692	0.0023	CbGeAlD
Sunitinib—ALK—lung—chronic obstructive pulmonary disease	0.000692	0.0023	CbGeAlD
Sunitinib—JAK2—bronchus—chronic obstructive pulmonary disease	0.000691	0.0023	CbGeAlD
Sunitinib—FLT1—connective tissue—chronic obstructive pulmonary disease	0.000689	0.00229	CbGeAlD
Sunitinib—TBK1—trachea—chronic obstructive pulmonary disease	0.000687	0.00229	CbGeAlD
Sunitinib—TNK1—lung—chronic obstructive pulmonary disease	0.000685	0.00228	CbGeAlD
Sunitinib—RIOK2—lung—chronic obstructive pulmonary disease	0.000685	0.00228	CbGeAlD
Sunitinib—TYK2—trachea—chronic obstructive pulmonary disease	0.000682	0.00227	CbGeAlD
Sunitinib—FYN—bronchus—chronic obstructive pulmonary disease	0.000682	0.00227	CbGeAlD
Sunitinib—FGFR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00068	0.00226	CbGeAlD
Sunitinib—MAP3K19—lung—chronic obstructive pulmonary disease	0.000678	0.00226	CbGeAlD
Sunitinib—MAP4K1—lung—chronic obstructive pulmonary disease	0.000678	0.00226	CbGeAlD
Sunitinib—JAK2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000677	0.00225	CbGeAlD
Sunitinib—FYN—smooth muscle tissue—chronic obstructive pulmonary disease	0.000667	0.00222	CbGeAlD
Sunitinib—MAP4K5—bronchus—chronic obstructive pulmonary disease	0.000666	0.00222	CbGeAlD
Sunitinib—MAP3K3—bronchus—chronic obstructive pulmonary disease	0.000666	0.00222	CbGeAlD
Sunitinib—DAPK3—lung—chronic obstructive pulmonary disease	0.000665	0.00221	CbGeAlD
Sunitinib—KDR—respiratory system—chronic obstructive pulmonary disease	0.000662	0.0022	CbGeAlD
Sunitinib—RPS6KB1—trachea—chronic obstructive pulmonary disease	0.000661	0.0022	CbGeAlD
Sunitinib—CLK2—lung—chronic obstructive pulmonary disease	0.000659	0.00219	CbGeAlD
Sunitinib—YES1—connective tissue—chronic obstructive pulmonary disease	0.000658	0.00219	CbGeAlD
Sunitinib—MAP4K2—lung—chronic obstructive pulmonary disease	0.000656	0.00218	CbGeAlD
Sunitinib—AXL—trachea—chronic obstructive pulmonary disease	0.000654	0.00218	CbGeAlD
Sunitinib—MAP4K5—smooth muscle tissue—chronic obstructive pulmonary disease	0.000652	0.00217	CbGeAlD
Sunitinib—TAOK3—connective tissue—chronic obstructive pulmonary disease	0.00065	0.00216	CbGeAlD
Sunitinib—STK3—lung—chronic obstructive pulmonary disease	0.000647	0.00215	CbGeAlD
Sunitinib—CSF1R—respiratory system—chronic obstructive pulmonary disease	0.000646	0.00215	CbGeAlD
Sunitinib—PDGFRA—connective tissue—chronic obstructive pulmonary disease	0.000646	0.00215	CbGeAlD
Sunitinib—FLT1—bronchus—chronic obstructive pulmonary disease	0.000644	0.00214	CbGeAlD
Sunitinib—ROCK1—lung—chronic obstructive pulmonary disease	0.000639	0.00213	CbGeAlD
Sunitinib—EPHB6—bronchus—chronic obstructive pulmonary disease	0.000637	0.00212	CbGeAlD
Sunitinib—FLT1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00063	0.0021	CbGeAlD
Sunitinib—SLK—trachea—chronic obstructive pulmonary disease	0.00063	0.0021	CbGeAlD
Sunitinib—DYRK1A—lung—chronic obstructive pulmonary disease	0.000623	0.00207	CbGeAlD
Sunitinib—JAK2—trachea—chronic obstructive pulmonary disease	0.000621	0.00207	CbGeAlD
Sunitinib—YES1—bronchus—chronic obstructive pulmonary disease	0.000616	0.00205	CbGeAlD
Sunitinib—FYN—trachea—chronic obstructive pulmonary disease	0.000612	0.00204	CbGeAlD
Sunitinib—STK10—bronchus—chronic obstructive pulmonary disease	0.00061	0.00203	CbGeAlD
Sunitinib—MERTK—lung—chronic obstructive pulmonary disease	0.000608	0.00202	CbGeAlD
Sunitinib—TAOK3—bronchus—chronic obstructive pulmonary disease	0.000608	0.00202	CbGeAlD
Sunitinib—YES1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000602	0.002	CbGeAlD
Sunitinib—MAP4K5—trachea—chronic obstructive pulmonary disease	0.000598	0.00199	CbGeAlD
Sunitinib—MAP3K3—trachea—chronic obstructive pulmonary disease	0.000598	0.00199	CbGeAlD
Sunitinib—MAP4K4—lung—chronic obstructive pulmonary disease	0.000597	0.00199	CbGeAlD
Sunitinib—NUAK2—lung—chronic obstructive pulmonary disease	0.000593	0.00197	CbGeAlD
Sunitinib—PDGFRA—smooth muscle tissue—chronic obstructive pulmonary disease	0.000591	0.00197	CbGeAlD
Sunitinib—FLT3—lung—chronic obstructive pulmonary disease	0.000589	0.00196	CbGeAlD
Sunitinib—MAP3K12—lung—chronic obstructive pulmonary disease	0.000589	0.00196	CbGeAlD
Sunitinib—KIT—respiratory system—chronic obstructive pulmonary disease	0.000587	0.00195	CbGeAlD
Sunitinib—KDR—connective tissue—chronic obstructive pulmonary disease	0.000583	0.00194	CbGeAlD
Sunitinib—RPS6KA3—lung—chronic obstructive pulmonary disease	0.000581	0.00193	CbGeAlD
Sunitinib—FLT1—trachea—chronic obstructive pulmonary disease	0.000579	0.00193	CbGeAlD
Sunitinib—MAP2K1—lung—chronic obstructive pulmonary disease	0.000577	0.00192	CbGeAlD
Sunitinib—PDGFRB—respiratory system—chronic obstructive pulmonary disease	0.000573	0.00191	CbGeAlD
Sunitinib—EPHB6—trachea—chronic obstructive pulmonary disease	0.000572	0.0019	CbGeAlD
Sunitinib—CSNK1A1—lung—chronic obstructive pulmonary disease	0.000569	0.00189	CbGeAlD
Sunitinib—CSF1R—connective tissue—chronic obstructive pulmonary disease	0.000569	0.00189	CbGeAlD
Sunitinib—CLK1—lung—chronic obstructive pulmonary disease	0.000566	0.00188	CbGeAlD
Sunitinib—CAMK2G—lung—chronic obstructive pulmonary disease	0.000555	0.00185	CbGeAlD
Sunitinib—BMP2K—lung—chronic obstructive pulmonary disease	0.000555	0.00185	CbGeAlD
Sunitinib—YES1—trachea—chronic obstructive pulmonary disease	0.000553	0.00184	CbGeAlD
Sunitinib—LRRK2—lung—chronic obstructive pulmonary disease	0.00055	0.00183	CbGeAlD
Sunitinib—TAOK3—trachea—chronic obstructive pulmonary disease	0.000546	0.00182	CbGeAlD
Sunitinib—KDR—bronchus—chronic obstructive pulmonary disease	0.000545	0.00181	CbGeAlD
Sunitinib—MAP2K5—bronchus—chronic obstructive pulmonary disease	0.000545	0.00181	CbGeAlD
Sunitinib—PRKAA1—lung—chronic obstructive pulmonary disease	0.000542	0.0018	CbGeAlD
Sunitinib—PDGFRA—trachea—chronic obstructive pulmonary disease	0.000542	0.0018	CbGeAlD
Sunitinib—PTK2B—lung—chronic obstructive pulmonary disease	0.000536	0.00178	CbGeAlD
Sunitinib—FLT4—lung—chronic obstructive pulmonary disease	0.000535	0.00178	CbGeAlD
Sunitinib—KDR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000533	0.00177	CbGeAlD
Sunitinib—CSF1R—bronchus—chronic obstructive pulmonary disease	0.000532	0.00177	CbGeAlD
Sunitinib—CSNK1E—lung—chronic obstructive pulmonary disease	0.000527	0.00176	CbGeAlD
Sunitinib—FGFR1—lung—chronic obstructive pulmonary disease	0.000527	0.00176	CbGeAlD
Sunitinib—CSF1R—smooth muscle tissue—chronic obstructive pulmonary disease	0.00052	0.00173	CbGeAlD
Sunitinib—IRAK4—lung—chronic obstructive pulmonary disease	0.000519	0.00173	CbGeAlD
Sunitinib—KIT—connective tissue—chronic obstructive pulmonary disease	0.000516	0.00172	CbGeAlD
Sunitinib—MAP2K2—lung—chronic obstructive pulmonary disease	0.000508	0.00169	CbGeAlD
Sunitinib—ULK3—lung—chronic obstructive pulmonary disease	0.000508	0.00169	CbGeAlD
Sunitinib—PDGFRB—connective tissue—chronic obstructive pulmonary disease	0.000504	0.00168	CbGeAlD
Sunitinib—MAP3K2—lung—chronic obstructive pulmonary disease	0.000504	0.00168	CbGeAlD
Sunitinib—MAP3K7—lung—chronic obstructive pulmonary disease	0.000499	0.00166	CbGeAlD
Sunitinib—TBK1—lung—chronic obstructive pulmonary disease	0.000494	0.00164	CbGeAlD
Sunitinib—TYK2—lung—chronic obstructive pulmonary disease	0.00049	0.00163	CbGeAlD
Sunitinib—KDR—trachea—chronic obstructive pulmonary disease	0.000489	0.00163	CbGeAlD
Sunitinib—MAP2K5—trachea—chronic obstructive pulmonary disease	0.000489	0.00163	CbGeAlD
Sunitinib—IRAK1—lung—chronic obstructive pulmonary disease	0.000484	0.00161	CbGeAlD
Sunitinib—KIT—bronchus—chronic obstructive pulmonary disease	0.000483	0.00161	CbGeAlD
Sunitinib—CSF1R—trachea—chronic obstructive pulmonary disease	0.000477	0.00159	CbGeAlD
Sunitinib—RPS6KB1—lung—chronic obstructive pulmonary disease	0.000475	0.00158	CbGeAlD
Sunitinib—KIT—smooth muscle tissue—chronic obstructive pulmonary disease	0.000472	0.00157	CbGeAlD
Sunitinib—FGR—lung—chronic obstructive pulmonary disease	0.000472	0.00157	CbGeAlD
Sunitinib—PDGFRB—bronchus—chronic obstructive pulmonary disease	0.000471	0.00157	CbGeAlD
Sunitinib—AXL—lung—chronic obstructive pulmonary disease	0.00047	0.00156	CbGeAlD
Sunitinib—PDGFRB—smooth muscle tissue—chronic obstructive pulmonary disease	0.000461	0.00154	CbGeAlD
Sunitinib—SLK—lung—chronic obstructive pulmonary disease	0.000453	0.00151	CbGeAlD
Sunitinib—FGFR2—lung—chronic obstructive pulmonary disease	0.000449	0.00149	CbGeAlD
Sunitinib—JAK2—lung—chronic obstructive pulmonary disease	0.000446	0.00148	CbGeAlD
Sunitinib—FYN—lung—chronic obstructive pulmonary disease	0.00044	0.00146	CbGeAlD
Sunitinib—KIT—trachea—chronic obstructive pulmonary disease	0.000433	0.00144	CbGeAlD
Sunitinib—MAP4K5—lung—chronic obstructive pulmonary disease	0.00043	0.00143	CbGeAlD
Sunitinib—MAP3K3—lung—chronic obstructive pulmonary disease	0.00043	0.00143	CbGeAlD
Sunitinib—PDGFRB—trachea—chronic obstructive pulmonary disease	0.000423	0.00141	CbGeAlD
Sunitinib—FLT1—lung—chronic obstructive pulmonary disease	0.000416	0.00138	CbGeAlD
Sunitinib—EPHB6—lung—chronic obstructive pulmonary disease	0.000411	0.00137	CbGeAlD
Sunitinib—YES1—lung—chronic obstructive pulmonary disease	0.000397	0.00132	CbGeAlD
Sunitinib—STK10—lung—chronic obstructive pulmonary disease	0.000394	0.00131	CbGeAlD
Sunitinib—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00123	CcSEcCtD
Sunitinib—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00123	CcSEcCtD
Sunitinib—TAOK3—lung—chronic obstructive pulmonary disease	0.000392	0.0013	CbGeAlD
Sunitinib—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00122	CcSEcCtD
Sunitinib—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00122	CcSEcCtD
Sunitinib—PDGFRA—lung—chronic obstructive pulmonary disease	0.00039	0.0013	CbGeAlD
Sunitinib—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000384	0.0012	CcSEcCtD
Sunitinib—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.0012	CcSEcCtD
Sunitinib—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00118	CcSEcCtD
Sunitinib—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000375	0.00125	CbGeAlD
Sunitinib—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000375	0.00117	CcSEcCtD
Sunitinib—Cough—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00117	CcSEcCtD
Sunitinib—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00117	CcSEcCtD
Sunitinib—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00116	CcSEcCtD
Sunitinib—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00116	CcSEcCtD
Sunitinib—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00116	CcSEcCtD
Sunitinib—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00116	CcSEcCtD
Sunitinib—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000369	0.00115	CcSEcCtD
Sunitinib—Cough—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00115	CcSEcCtD
Sunitinib—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00114	CcSEcCtD
Sunitinib—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00114	CcSEcCtD
Sunitinib—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00114	CcSEcCtD
Sunitinib—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00114	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00114	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00114	CcSEcCtD
Sunitinib—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00112	CcSEcCtD
Sunitinib—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00112	CcSEcCtD
Sunitinib—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00112	CcSEcCtD
Sunitinib—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00112	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00111	CcSEcCtD
Sunitinib—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00111	CcSEcCtD
Sunitinib—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00111	CcSEcCtD
Sunitinib—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00111	CcSEcCtD
Sunitinib—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000353	0.0011	CcSEcCtD
Sunitinib—KDR—lung—chronic obstructive pulmonary disease	0.000351	0.00117	CbGeAlD
Sunitinib—MAP2K5—lung—chronic obstructive pulmonary disease	0.000351	0.00117	CbGeAlD
Sunitinib—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.0011	CcSEcCtD
Sunitinib—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000351	0.0011	CcSEcCtD
Sunitinib—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00109	CcSEcCtD
Sunitinib—Infection—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00109	CcSEcCtD
Sunitinib—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00109	CcSEcCtD
Sunitinib—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00108	CcSEcCtD
Sunitinib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00108	CcSEcCtD
Sunitinib—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00108	CcSEcCtD
Sunitinib—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00108	CcSEcCtD
Sunitinib—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00107	CcSEcCtD
Sunitinib—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00107	CcSEcCtD
Sunitinib—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.00107	CcSEcCtD
Sunitinib—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00107	CcSEcCtD
Sunitinib—CSF1R—lung—chronic obstructive pulmonary disease	0.000343	0.00114	CbGeAlD
Sunitinib—Infection—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00107	CcSEcCtD
Sunitinib—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00106	CcSEcCtD
Sunitinib—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00106	CcSEcCtD
Sunitinib—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00106	CcSEcCtD
Sunitinib—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00106	CcSEcCtD
Sunitinib—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00106	CcSEcCtD
Sunitinib—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00105	CcSEcCtD
Sunitinib—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00105	CcSEcCtD
Sunitinib—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.00105	CcSEcCtD
Sunitinib—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00105	CcSEcCtD
Sunitinib—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00104	CcSEcCtD
Sunitinib—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00103	CcSEcCtD
Sunitinib—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00103	CcSEcCtD
Sunitinib—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00102	CcSEcCtD
Sunitinib—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.00102	CcSEcCtD
Sunitinib—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00102	CcSEcCtD
Sunitinib—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00101	CcSEcCtD
Sunitinib—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.001	CcSEcCtD
Sunitinib—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.001	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.000998	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000319	0.000998	CcSEcCtD
Sunitinib—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000317	0.000991	CcSEcCtD
Sunitinib—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.000991	CcSEcCtD
Sunitinib—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000986	CcSEcCtD
Sunitinib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.000985	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000313	0.000978	CcSEcCtD
Sunitinib—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000313	0.000977	CcSEcCtD
Sunitinib—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.000977	CcSEcCtD
Sunitinib—KIT—lung—chronic obstructive pulmonary disease	0.000311	0.00104	CbGeAlD
Sunitinib—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000311	0.000971	CcSEcCtD
Sunitinib—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000967	CcSEcCtD
Sunitinib—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000309	0.000965	CcSEcCtD
Sunitinib—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.000965	CcSEcCtD
Sunitinib—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000308	0.000964	CcSEcCtD
Sunitinib—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.000961	CcSEcCtD
Sunitinib—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.000952	CcSEcCtD
Sunitinib—PDGFRB—lung—chronic obstructive pulmonary disease	0.000304	0.00101	CbGeAlD
Sunitinib—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.000946	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000303	0.000946	CcSEcCtD
Sunitinib—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000945	CcSEcCtD
Sunitinib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000302	0.000945	CcSEcCtD
Sunitinib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.000945	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000943	CcSEcCtD
Sunitinib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.000937	CcSEcCtD
Sunitinib—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.000937	CcSEcCtD
Sunitinib—Pain—Formoterol—chronic obstructive pulmonary disease	0.0003	0.000937	CcSEcCtD
Sunitinib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0003	0.000937	CcSEcCtD
Sunitinib—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000936	CcSEcCtD
Sunitinib—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000299	0.000995	CbGeAlD
Sunitinib—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.000929	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000927	CcSEcCtD
Sunitinib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000925	CcSEcCtD
Sunitinib—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000922	CcSEcCtD
Sunitinib—Pain—Montelukast—chronic obstructive pulmonary disease	0.000294	0.000918	CcSEcCtD
Sunitinib—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.000917	CcSEcCtD
Sunitinib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.000915	CcSEcCtD
Sunitinib—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000912	CcSEcCtD
Sunitinib—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000911	CcSEcCtD
Sunitinib—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.000908	CcSEcCtD
Sunitinib—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.000907	CcSEcCtD
Sunitinib—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.000902	CcSEcCtD
Sunitinib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000899	CcSEcCtD
Sunitinib—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000899	CcSEcCtD
Sunitinib—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.000898	CcSEcCtD
Sunitinib—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000287	0.000896	CcSEcCtD
Sunitinib—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.000896	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.000893	CcSEcCtD
Sunitinib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.000892	CcSEcCtD
Sunitinib—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.000885	CcSEcCtD
Sunitinib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.000885	CcSEcCtD
Sunitinib—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000878	CcSEcCtD
Sunitinib—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000866	CcSEcCtD
Sunitinib—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000866	CcSEcCtD
Sunitinib—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000866	CcSEcCtD
Sunitinib—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000866	CcSEcCtD
Sunitinib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.000863	CcSEcCtD
Sunitinib—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.000856	CcSEcCtD
Sunitinib—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.000855	CcSEcCtD
Sunitinib—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.000855	CcSEcCtD
Sunitinib—CSNK1E—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000272	0.0395	CbGdCrCtD
Sunitinib—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.000851	CcSEcCtD
Sunitinib—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00085	CcSEcCtD
Sunitinib—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000848	CcSEcCtD
Sunitinib—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000848	CcSEcCtD
Sunitinib—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000847	CcSEcCtD
Sunitinib—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.000846	CcSEcCtD
Sunitinib—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000839	CcSEcCtD
Sunitinib—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.000835	CcSEcCtD
Sunitinib—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.000818	CcSEcCtD
Sunitinib—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.000818	CcSEcCtD
Sunitinib—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.000807	CcSEcCtD
Sunitinib—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000258	0.000807	CcSEcCtD
Sunitinib—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.000806	CcSEcCtD
Sunitinib—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000804	CcSEcCtD
Sunitinib—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000798	CcSEcCtD
Sunitinib—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000253	0.000791	CcSEcCtD
Sunitinib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.000786	CcSEcCtD
Sunitinib—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000252	0.000786	CcSEcCtD
Sunitinib—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000775	CcSEcCtD
Sunitinib—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000775	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000774	CcSEcCtD
Sunitinib—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000774	CcSEcCtD
Sunitinib—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00077	CcSEcCtD
Sunitinib—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000763	CcSEcCtD
Sunitinib—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.000762	CcSEcCtD
Sunitinib—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000759	CcSEcCtD
Sunitinib—ABCC4—lung—chronic obstructive pulmonary disease	0.000242	0.000806	CbGeAlD
Sunitinib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00075	CcSEcCtD
Sunitinib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00075	CcSEcCtD
Sunitinib—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000746	CcSEcCtD
Sunitinib—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000743	CcSEcCtD
Sunitinib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000742	CcSEcCtD
Sunitinib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000235	0.000734	CcSEcCtD
Sunitinib—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000732	CcSEcCtD
Sunitinib—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.000727	CcSEcCtD
Sunitinib—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.000725	CcSEcCtD
Sunitinib—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000232	0.000725	CcSEcCtD
Sunitinib—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00071	CcSEcCtD
Sunitinib—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000709	CcSEcCtD
Sunitinib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000708	CcSEcCtD
Sunitinib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.000697	CcSEcCtD
Sunitinib—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000223	0.000697	CcSEcCtD
Sunitinib—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.000691	CcSEcCtD
Sunitinib—Rash—Formoterol—chronic obstructive pulmonary disease	0.000221	0.000691	CcSEcCtD
Sunitinib—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00069	CcSEcCtD
Sunitinib—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00069	CcSEcCtD
Sunitinib—Headache—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000686	CcSEcCtD
Sunitinib—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000686	CcSEcCtD
Sunitinib—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000686	CcSEcCtD
Sunitinib—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.000684	CcSEcCtD
Sunitinib—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000684	CcSEcCtD
Sunitinib—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000682	CcSEcCtD
Sunitinib—Rash—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000677	CcSEcCtD
Sunitinib—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000216	0.000676	CcSEcCtD
Sunitinib—Depression—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000674	CcSEcCtD
Sunitinib—Headache—Montelukast—chronic obstructive pulmonary disease	0.000215	0.000672	CcSEcCtD
Sunitinib—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000667	CcSEcCtD
Sunitinib—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000664	CcSEcCtD
Sunitinib—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000663	CcSEcCtD
Sunitinib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000658	CcSEcCtD
Sunitinib—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000652	CcSEcCtD
Sunitinib—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000652	CcSEcCtD
Sunitinib—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000208	0.000651	CcSEcCtD
Sunitinib—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.000651	CcSEcCtD
Sunitinib—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000648	CcSEcCtD
Sunitinib—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000204	0.000637	CcSEcCtD
Sunitinib—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00063	CcSEcCtD
Sunitinib—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000628	CcSEcCtD
Sunitinib—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000618	CcSEcCtD
Sunitinib—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000615	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00061	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000607	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000596	CcSEcCtD
Sunitinib—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000593	CcSEcCtD
Sunitinib—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000584	CcSEcCtD
Sunitinib—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000567	CcSEcCtD
Sunitinib—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000563	CcSEcCtD
Sunitinib—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000551	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000548	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000174	0.0252	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000174	0.0252	CbGdCrCtD
Sunitinib—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000542	CcSEcCtD
Sunitinib—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000537	CcSEcCtD
Sunitinib—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000536	CcSEcCtD
Sunitinib—ABCG2—lung—chronic obstructive pulmonary disease	0.000171	0.000569	CbGeAlD
Sunitinib—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.000533	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000532	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.0246	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.0246	CbGdCrCtD
Sunitinib—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000528	CcSEcCtD
Sunitinib—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000528	CcSEcCtD
Sunitinib—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000507	CcSEcCtD
Sunitinib—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000159	0.000528	CbGeAlD
Sunitinib—CYP3A5—lung—chronic obstructive pulmonary disease	0.000159	0.000528	CbGeAlD
Sunitinib—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000488	CcSEcCtD
Sunitinib—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000483	CcSEcCtD
Sunitinib—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000458	CcSEcCtD
Sunitinib—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000456	CcSEcCtD
Sunitinib—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00045	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00045	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000447	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000437	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000139	0.0202	CbGdCrCtD
Sunitinib—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000431	CcSEcCtD
Sunitinib—Infection—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000428	CcSEcCtD
Sunitinib—Shock—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000424	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000423	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000419	CcSEcCtD
Sunitinib—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000411	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000393	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000392	CcSEcCtD
Sunitinib—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00039	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000387	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00038	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000375	CcSEcCtD
Sunitinib—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000374	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000374	CcSEcCtD
Sunitinib—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000372	CcSEcCtD
Sunitinib—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000372	CcSEcCtD
Sunitinib—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000369	CcSEcCtD
Sunitinib—ABCB1—trachea—chronic obstructive pulmonary disease	0.000117	0.000391	CbGeAlD
Sunitinib—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000353	CcSEcCtD
Sunitinib—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000352	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000341	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000341	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000318	CcSEcCtD
Sunitinib—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000309	CcSEcCtD
Sunitinib—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000305	CcSEcCtD
Sunitinib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000295	CcSEcCtD
Sunitinib—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000285	CcSEcCtD
Sunitinib—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000274	CcSEcCtD
Sunitinib—Rash—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000272	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000272	CcSEcCtD
Sunitinib—Headache—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.00027	CcSEcCtD
Sunitinib—ABCB1—lung—chronic obstructive pulmonary disease	8.43e-05	0.000281	CbGeAlD
Sunitinib—Nausea—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000256	CcSEcCtD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.21e-06	1.4e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.17e-06	1.39e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.14e-06	1.38e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.14e-06	1.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.11e-06	1.37e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.09e-06	1.37e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.07e-06	1.36e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.07e-06	1.36e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EGFR—chronic obstructive pulmonary disease	5.07e-06	1.36e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.06e-06	1.36e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.06e-06	1.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.05e-06	1.35e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—chronic obstructive pulmonary disease	5.04e-06	1.35e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.04e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EGFR—chronic obstructive pulmonary disease	5.01e-06	1.34e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.99e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.99e-06	1.34e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.95e-06	1.33e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.92e-06	1.32e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—EGFR—chronic obstructive pulmonary disease	4.92e-06	1.32e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EGFR—chronic obstructive pulmonary disease	4.92e-06	1.32e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.9e-06	1.32e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.9e-06	1.32e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.87e-06	1.31e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.87e-06	1.31e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.86e-06	1.3e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.85e-06	1.3e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.85e-06	1.3e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.83e-06	1.3e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.82e-06	1.29e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—chronic obstructive pulmonary disease	4.77e-06	1.28e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.77e-06	1.28e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.74e-06	1.27e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—chronic obstructive pulmonary disease	4.71e-06	1.26e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.7e-06	1.26e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.69e-06	1.26e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—EGFR—chronic obstructive pulmonary disease	4.68e-06	1.26e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-06	1.25e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EGFR—chronic obstructive pulmonary disease	4.67e-06	1.25e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EGFR—chronic obstructive pulmonary disease	4.65e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.65e-06	1.25e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.64e-06	1.25e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—chronic obstructive pulmonary disease	4.63e-06	1.24e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.62e-06	1.24e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EGFR—chronic obstructive pulmonary disease	4.62e-06	1.24e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.62e-06	1.24e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.56e-06	1.22e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—EGFR—chronic obstructive pulmonary disease	4.54e-06	1.22e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.53e-06	1.22e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.52e-06	1.21e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.49e-06	1.2e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.48e-06	1.2e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.47e-06	1.2e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.45e-06	1.19e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.45e-06	1.19e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.43e-06	1.19e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.43e-06	1.19e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.41e-06	1.18e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.4e-06	1.18e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—chronic obstructive pulmonary disease	4.39e-06	1.18e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—chronic obstructive pulmonary disease	4.38e-06	1.18e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.38e-06	1.18e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.37e-06	1.17e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.35e-06	1.17e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.35e-06	1.17e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.34e-06	1.16e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EGFR—chronic obstructive pulmonary disease	4.31e-06	1.16e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EGFR—chronic obstructive pulmonary disease	4.3e-06	1.15e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EGFR—chronic obstructive pulmonary disease	4.3e-06	1.15e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	1.15e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	1.15e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.29e-06	1.15e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.28e-06	1.15e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.26e-06	1.14e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—chronic obstructive pulmonary disease	4.23e-06	1.14e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.22e-06	1.13e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-06	1.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.21e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.2e-06	1.13e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EGFR—chronic obstructive pulmonary disease	4.19e-06	1.13e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.19e-06	1.12e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.18e-06	1.12e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.18e-06	1.12e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.18e-06	1.12e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.15e-06	1.11e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.13e-06	1.11e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.12e-06	1.1e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.1e-06	1.1e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.09e-06	1.1e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-06	1.09e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.06e-06	1.09e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—chronic obstructive pulmonary disease	4.05e-06	1.09e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—EGFR—chronic obstructive pulmonary disease	4.04e-06	1.08e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.03e-06	1.08e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.03e-06	1.08e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EGFR—chronic obstructive pulmonary disease	4.02e-06	1.08e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—chronic obstructive pulmonary disease	4.01e-06	1.08e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.01e-06	1.08e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.01e-06	1.08e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.01e-06	1.07e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EGFR—chronic obstructive pulmonary disease	3.97e-06	1.06e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.96e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—chronic obstructive pulmonary disease	3.95e-06	1.06e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.93e-06	1.06e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.93e-06	1.06e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—chronic obstructive pulmonary disease	3.9e-06	1.05e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	1.04e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EGFR—chronic obstructive pulmonary disease	3.87e-06	1.04e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	1.03e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—chronic obstructive pulmonary disease	3.85e-06	1.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EGFR—chronic obstructive pulmonary disease	3.84e-06	1.03e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.84e-06	1.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.83e-06	1.03e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.81e-06	1.02e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—chronic obstructive pulmonary disease	3.81e-06	1.02e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.8e-06	1.02e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.8e-06	1.02e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—chronic obstructive pulmonary disease	3.79e-06	1.02e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—chronic obstructive pulmonary disease	3.78e-06	1.01e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—chronic obstructive pulmonary disease	3.78e-06	1.01e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.75e-06	1.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.73e-06	1e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—chronic obstructive pulmonary disease	3.73e-06	1e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.72e-06	9.99e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—chronic obstructive pulmonary disease	3.71e-06	9.96e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.71e-06	9.96e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.71e-06	9.95e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.67e-06	9.84e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.66e-06	9.82e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.64e-06	9.77e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.64e-06	9.77e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.63e-06	9.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—chronic obstructive pulmonary disease	3.62e-06	9.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.61e-06	9.7e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—chronic obstructive pulmonary disease	3.6e-06	9.65e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.6e-06	9.65e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—chronic obstructive pulmonary disease	3.59e-06	9.62e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—chronic obstructive pulmonary disease	3.58e-06	9.6e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.58e-06	9.59e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.56e-06	9.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.56e-06	9.54e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—chronic obstructive pulmonary disease	3.55e-06	9.53e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—chronic obstructive pulmonary disease	3.55e-06	9.52e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.53e-06	9.48e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.53e-06	9.48e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.53e-06	9.48e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.53e-06	9.48e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—chronic obstructive pulmonary disease	3.49e-06	9.36e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.48e-06	9.35e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.44e-06	9.24e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.44e-06	9.24e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.44e-06	9.22e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.41e-06	9.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.4e-06	9.12e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.38e-06	9.07e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.38e-06	9.06e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.36e-06	9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.35e-06	9e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.35e-06	8.99e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.34e-06	8.97e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.34e-06	8.97e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.33e-06	8.95e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—chronic obstructive pulmonary disease	3.31e-06	8.88e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—chronic obstructive pulmonary disease	3.3e-06	8.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—chronic obstructive pulmonary disease	3.3e-06	8.86e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.3e-06	8.86e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.3e-06	8.85e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.28e-06	8.79e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.26e-06	8.75e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.24e-06	8.7e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.24e-06	8.7e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.24e-06	8.68e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.23e-06	8.68e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.23e-06	8.67e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.23e-06	8.67e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.23e-06	8.67e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.23e-06	8.67e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—chronic obstructive pulmonary disease	3.22e-06	8.65e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.22e-06	8.63e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.18e-06	8.53e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.18e-06	8.53e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.15e-06	8.45e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—chronic obstructive pulmonary disease	3.11e-06	8.33e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—chronic obstructive pulmonary disease	3.09e-06	8.29e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.09e-06	8.28e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.08e-06	8.26e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.07e-06	8.25e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.07e-06	8.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—chronic obstructive pulmonary disease	3.05e-06	8.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.02e-06	8.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.01e-06	8.08e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.01e-06	8.07e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.99e-06	8.02e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—chronic obstructive pulmonary disease	2.98e-06	7.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.98e-06	7.98e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—chronic obstructive pulmonary disease	2.95e-06	7.92e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	2.91e-06	7.81e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.9e-06	7.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.89e-06	7.75e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—chronic obstructive pulmonary disease	2.87e-06	7.69e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—chronic obstructive pulmonary disease	2.85e-06	7.65e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.83e-06	7.61e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.83e-06	7.6e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.79e-06	7.47e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.78e-06	7.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.77e-06	7.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.76e-06	7.41e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.75e-06	7.38e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.74e-06	7.35e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.74e-06	7.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—chronic obstructive pulmonary disease	2.73e-06	7.31e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.72e-06	7.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.71e-06	7.27e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.67e-06	7.16e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.67e-06	7.16e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.67e-06	7.15e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.65e-06	7.11e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.61e-06	7.01e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.6e-06	6.97e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.59e-06	6.96e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.53e-06	6.8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.53e-06	6.8e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.53e-06	6.78e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.52e-06	6.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.49e-06	6.67e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.48e-06	6.66e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.44e-06	6.56e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.44e-06	6.56e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.33e-06	6.26e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.32e-06	6.22e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.31e-06	6.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.29e-06	6.13e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.28e-06	6.11e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.25e-06	6.05e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.2e-06	5.9e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.19e-06	5.89e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.18e-06	5.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.14e-06	5.73e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.1e-06	5.64e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.1e-06	5.64e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.09e-06	5.6e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.08e-06	5.59e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.01e-06	5.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2e-06	5.36e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.99e-06	5.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.91e-06	5.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.35e-06	3.63e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-06	3.47e-06	CbGpPWpGaD
